Indication for percutaneous aortic valve implantation

Archives of Medical Science

Volumn 6, Issue 3, 2010, Pages 296-302

  Akin, Ibrahim ^a   Kische, Stephan ^a   Rehders, Tim C ^a   Nienaber, Christoph A ^a   Rauchhaus, Mathias ^a   Ince, Hüseyin ^a   Schneider, Henrik ^a   Liebold, Andreas ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

Aortic stenosis; CoreValve; Edwards SAPIEN; EuroScore

Indexed keywords

AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; AORTOGRAPHY; BALLOON CATHETER; BLOOD VESSEL DIAMETER; CALCIFICATION; CONVENTIONAL ANGIOGRAPHY; DOPPLER ECHOCARDIOGRAPHY; FEASIBILITY STUDY; HUMAN; LIFE EXPECTANCY; MORTALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS AORTIC VALVE IMPLANTATION; QUALITY OF LIFE; REVIEW; STENT; SURGICAL RISK; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EID: 77954304444     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2010.14247     Document Type: Review

References (20)

1. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart disease: a population-based study. Lancet 2006; 368: 1005-11.
2. Kvidal P, Bergstrom R, Horte LG, Stänk E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000; 35: 747-56. (Pubitemid 30167033)
3. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005; 26: 2714-20.
4. Varadarajan P, Kapoor N, Bansal RC, Pai RG. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg 2006; 82: 2111-5.
5. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for paients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008; 29: 1463-70.
6. Zegdi R, Ciobotaru V, Noghin M, et al. Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results from a human anatomic study in adults. J Am Coll Cardiol 2008; 51: 579-84.
7. Roques F, Nashef SA, Michel P; EuroSCORE Study Group. Risk factors for early mortality after valve surgery in Euro in the 1990's: lesson from the EuroSCORE pilot program. J Heart Valve Dis 2001; 10: 572-8. (Pubitemid 32962904)
8. Grossi EA, Schwartz CF, Yu PJ, Jorde UP, Crooke GA, Grang B. High-risk aortic valve replacement: are the outcomes as bad as predicted? Ann Thorac Surg 2008; 85: 102-6.
9. Moss RR, Ivens E, Pasupati S, et al. Role of echocardiography in percutaneous aortic valve replacement. JACC Cardiovasc Imaging 2008; 1: 15-24.
10. Babaliaros VC, Liff D, Chen EP, et al. Can balloon aortic valvuloplasty help determine appropriate transcatheter aortic valve size? JACC Intv 2008; 1: 580-6.
11. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106: 3006-8. (Pubitemid 35440280)
12. Cribrier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004; 43: 698-703. (Pubitemid 38229547)
13. Cribrier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: midterm follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006; 47: 1214-23.
14. Walther T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007; 116 (Suppl 11): I240-5.
15. Grube E, Laborde JC, Zickmann B, et al. First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv 2005; 66: 465-9. (Pubitemid 41779008)
16. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: Siegburg first-in-man study. Circulation 2006; 114: 1616-24.
17. Grube E, Buellesfeld L, Mueller R. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Intervent 2008; 1: 167-75.
18. Piazza N, Grube E, Gerckens U, den Hejers P, Linke A. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntv 2008; 4: 242-9.
19. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007; 116: 755-63. (Pubitemid 47255993)
20. Walther T, Dewey T, Borger MA, et al. Transapical aortic valve implantation: stepp by stepp. Ann Thorac Surg 2009; 87: 276-83.